Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Isoniazid for INH-Resistant TB
NCT01936831Phase 2Completed
- Start
- Aug 2014
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of isoniazid in pulmonary tuberculosis (TB). Started Aug 2014; status: completed.
02
Drugs
isoniazid
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT01936831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01936831.